IL159792A0 - Variolin derivatives and pharmaceutical compositions containing the same - Google Patents

Variolin derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL159792A0
IL159792A0 IL15979202A IL15979202A IL159792A0 IL 159792 A0 IL159792 A0 IL 159792A0 IL 15979202 A IL15979202 A IL 15979202A IL 15979202 A IL15979202 A IL 15979202A IL 159792 A0 IL159792 A0 IL 159792A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
substituted
unsubstituted
Prior art date
Application number
IL15979202A
Other languages
English (en)
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of IL159792A0 publication Critical patent/IL159792A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15979202A 2001-07-11 2002-07-11 Variolin derivatives and pharmaceutical compositions containing the same IL159792A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116966.3A GB0116966D0 (en) 2001-07-11 2001-07-11 Anittumoral compounds
PCT/GB2002/003197 WO2003006457A1 (en) 2001-07-11 2002-07-11 Variolin derivatives and their use as antitumor agents

Publications (1)

Publication Number Publication Date
IL159792A0 true IL159792A0 (en) 2004-06-20

Family

ID=9918335

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15979202A IL159792A0 (en) 2001-07-11 2002-07-11 Variolin derivatives and pharmaceutical compositions containing the same
IL159792A IL159792A (en) 2001-07-11 2004-01-11 History of variolins and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159792A IL159792A (en) 2001-07-11 2004-01-11 History of variolins and pharmaceutical preparations containing them

Country Status (19)

Country Link
US (2) US7495000B2 (de)
EP (2) EP1404668B1 (de)
JP (1) JP4369225B2 (de)
KR (1) KR100929616B1 (de)
CN (1) CN1553906B (de)
AT (2) ATE396987T1 (de)
AU (1) AU2002317329B2 (de)
CA (1) CA2453418C (de)
DE (2) DE60226869D1 (de)
ES (2) ES2354991T3 (de)
GB (1) GB0116966D0 (de)
HU (1) HUP0402658A2 (de)
IL (2) IL159792A0 (de)
MX (1) MXPA04000355A (de)
NO (1) NO328848B1 (de)
NZ (1) NZ530556A (de)
PL (1) PL366894A1 (de)
RU (1) RU2302419C2 (de)
WO (1) WO2003006457A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001270783B2 (en) 2000-07-11 2006-06-15 Pharma Mar, S.A. Variolin derivatives as anti-cancer agents
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds
AR072092A1 (es) * 2008-06-11 2010-08-04 Genentech Inc Diazacarbazoles y metodos de uso
US11332480B2 (en) 2017-04-27 2022-05-17 Pharma Mar, S.A. Antitumoral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001270783B2 (en) * 2000-07-11 2006-06-15 Pharma Mar, S.A. Variolin derivatives as anti-cancer agents
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds

Also Published As

Publication number Publication date
US20060235223A1 (en) 2006-10-19
US7495000B2 (en) 2009-02-24
NO328848B1 (no) 2010-05-31
HK1060354A1 (en) 2004-08-06
EP1867645A1 (de) 2007-12-19
JP2004536850A (ja) 2004-12-09
DE60226869D1 (de) 2008-07-10
ES2307768T3 (es) 2008-12-01
KR20040023649A (ko) 2004-03-18
IL159792A (en) 2009-08-03
EP1404668B1 (de) 2008-05-28
JP4369225B2 (ja) 2009-11-18
PL366894A1 (en) 2005-02-07
CN1553906B (zh) 2010-04-28
DE60237652D1 (de) 2010-10-21
WO2003006457A1 (en) 2003-01-23
KR100929616B1 (ko) 2009-12-03
RU2302419C2 (ru) 2007-07-10
AU2002317329B2 (en) 2008-10-02
EP1867645B1 (de) 2010-09-08
ATE480533T1 (de) 2010-09-15
CA2453418A1 (en) 2003-01-23
US7772241B2 (en) 2010-08-10
NO20040113L (no) 2004-03-09
CN1553906A (zh) 2004-12-08
GB0116966D0 (en) 2001-09-05
ATE396987T1 (de) 2008-06-15
MXPA04000355A (es) 2005-03-07
ES2354991T3 (es) 2011-03-21
RU2004103857A (ru) 2005-06-20
CA2453418C (en) 2011-05-17
US20090197901A1 (en) 2009-08-06
EP1404668A1 (de) 2004-04-07
HUP0402658A2 (hu) 2005-04-28
NZ530556A (en) 2005-07-29

Similar Documents

Publication Publication Date Title
MXPA04001240A (es) Analogos antitumorales.
IL144461A0 (en) Quinoline and quinazoline derivatives and pharmaceutical compositions containing them
DK0622361T3 (da) Heterocykliske forbindelser som bradykininantagonister
ATE303063T1 (de) Synthetische analoge des ecteinascidin-743
CY1113359T1 (el) Αντι-νεοπλασιακα παραγωγα του et-743
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
DE69010100D1 (de) Pyrimidinyl herbizides Mittel.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
GB0116966D0 (en) Anittumoral compounds
IL153682A0 (en) Variolin derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
GB2334032A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
EP0315434A3 (de) Pyridoxalhydrazon-Derivate, ihre Herstellung und Verwendung und diese enthaltende Arzneimittel
YU74501A (sh) Sinteza 3-amino-3-aril propionata
NO20041250L (no) Vannopploselige fenylpyridazinderivater og medikamenter inneholdende disse.
AU3387301A (en) Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
MY104164A (en) Heterocyclic compounds.